We report retrospectively on the skin manifestations of 36 patients presenting to five hospitals in south-east Queensland with a serologically confirmed spotted fever group rickettsia infection. Of the 36 patients 30 (83%) had documented cutaneous involvement, and of the latter 12 (36%) underwent a skin biopsy. With regard to morphology, a maculopapular eruption was reported in most of these patients (21/30; 70%); while a macular, vesicular and purpura rash was found in 17, 10 and 3% of this group, respectively. A non-blanching rash was reported in 6/30 (20%) patients (Fig. 2) . Eschar was noted in 6/30 (20%) and a visible tick bite was seen in 17/30 (57%). The distribution of the cutaneous changes was mainly global (21/30; 70%); while it was found on the lower limbs, upper limbs and trunk of 13, 10 and 7% of these patients, respectively. The body distribution of the rash appeared to reflect the location of the tick bite and eschar. The median duration of the cutaneous changes was 18.6 days.
Skin histopathology findings were varied. A perivascular inflammatory infiltrate with features of vasculitis was common (10/12; 83%). A predominantly lymphocytic infiltrate was seen in 6/10 (60%), with predominantly neutrophilic and mixed infiltrates (including plasma cells, eosinophils and histiocytes) affecting 20% each (Fig. 3) . Although sparing the post-capillary venules is thought to suggest rickettsial disease, most samples exhibited involvement of both dermal arterioles and venules. Erythrocyte extravasation in association with vasculitis was seen in 2/12 (17%) patients. Two samples showed extensive inflammation and damage of the eccrine ducts as well as the blood vessels. Ulceration and superficial dermal necrosis were present in 33%, with one showing extension into the s.c. tissue. One sample demonstrated sub-epidermal bulla that was cellpoor, with large fibrin thrombi found in medium-sized vessels. The epidermis was usually spared. A polymerase chain reaction test of skin biopsy samples for spotted fever group Rickettsia spp. was performed in four patients, with positivity found in only one.
We present the dermatological features observed in 36 patients with confirmed spotted fever group rickettsial infection in Australia. There are currently no known specific or pathognomonic skin morphological or histopathological features of spotted fever group rickettsial disease. Moreover, the characteristics of cutaneous changes may be largely a feature of the time taken to present following inoculation from a tick bite, as well as the severity of illness, often with more severe skin findings seen later in the disease course.
1 Given such variability, acute rickettsial disease has often been confused with autoimmune vasculitis, acute neutrophilic dermatosis, drug exanthem and viral infection, including varicella. 6 Dermatological manifestations are often the main presenting feature of illness and a skin biopsy is often used to aid clinical diagnosis, although its efficaciousness is undetermined. A skin biopsy can be very useful in the early identification of other more sinister causes of acute fever and rash. It has been proposed that the spotted fever group Rickettsia spp. polymerase chain reaction test on eschar tissue is more sensitive than initial serological testing in detecting acute infection. 7, 8 The multiplication of Rickettsia in the target cells is greatest at the inoculation site and in the resultant eschar, as shown in a murine model. 9 The accurate and timely diagnosis of spotted fever group rickettsial infection is likely to continue to rely on an accurate epidemiological history as well as associated features of the infection such as lymphadenopathy, thrombocytopenia and elevated transaminases. Often a therapeutic trial of doxycycline is needed to confirm evidence of infection, as rapid clinical improvement is expected with early treatment. (Fig. 2) showing superficial and deep subacute vasculitis with predominant lymphocytic infiltrate and fibrinoid necrosis of vessels (H&E, 940 magnification).
